A dual-action nanomaterial uses cancer’s own chemistry to destroy tumors while leaving healthy cells unharmed.

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

Scientists in China have unveiled a breakthrough way to mass-produce powerful cancer-fighting immune cells in the lab. By ...

Researchers expanded millions of cancer-targeting NK cells from a single donor, improving manufacturing for future therapies.

Engineered yeast cells can mimic real cancer cells and be used to test new cancer immunotherapies much faster, benefiting patients.

Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers. Now, a new study suggests that blocking a key protein, p300, may force damaged ...

Can fragments of tumor DNA in the blood predict whether chemotherapy will be effective? Researchers at the Princess Máxima Center investigated this question together with experts from Italy and ...

Johnson & Johnson, the healthcare and lifestyle giant announced a more than $1 billion dollar investment in next generation ...

The National Cancer Institute has quietly moved a familiar and polarizing drug into its preclinical pipeline: ivermectin, ...

Postpartum breast cancer is diagnosed five to ten years after giving birth. It is associated with a higher risk of metastasis and a lower survival rate compared with women who have not been pregnant ...